A graduate of the University of Ibadan, UI, who wrote JAMB multiple times shares her story as she finishes with a first class degree despite a low CGPA in 100 level.

On March 12, Faith Sisters Bible Study and Fellowship meet at 7 p.m. Visit fccmanhattan.org for more information. Join us for worship in person at 10:45 a.m. Sunday. Rev. Caela Simmons Wood will ...

Data readout for SIM0505/CDH6 ADC Phase 1 dose escalation study and initiation of dose optimization in ovarian cancer are both anticipated in Q2 2026LNCB74 Phase 1 dose escalation trial update planned ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, 'Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data at ...